Phibro Animal Health Corp(NASDAQ:PAHC) announced the earnings results for Fiscal Year 2017 and Q2. The results came in during After-Market on Feb 6, 2017. Company reported revenue of $191.598M. Analysts estimated a revenue of $194.160M. The revenues were -1.32% below the estimates. Earnings per share were $0.39. The reported EPS was above estimates by 11.43%. Analysts had estimated an EPS of $0.35.
In a different note, PiperJaffray said it Initiates Coverage On Phibro Animal Health Corp, according to a research note issued on Dec 15, 2016. In the research note, the firm Announces the price-target to $32 per share. The shares have been rated ‘Overweight’ by the firm.
Phibro Animal Health Corp (PAHC) made into the market gainers list on Tuesdays trading session with the shares advancing 3.93% or 1.1 points. Due to strong positive momentum, the stock ended at $29.1, which is also near the day’s high of $29.7. The stock began the session at $29.05 and the volume stood at 5,30,270 shares. The 52-week high of the shares is $34.54 and the 52 week low is $16.8. The company has a current market capitalization of $1,147 M and it has 3,94,07,568 shares in outstanding.
Several Insider Transactions has been reported to the SEC. On Jan 5, 2017, Larry Lee Miller (Chief Operating Officer) sold 187 shares at $30.00 per share price.Also, On Jan 5, 2017, Thomas G Dagger (SVP, GC and Corp Secretary) sold 207 shares at $30.00 per share price.On May 23, 2016, E Thomas Corcoran (director) purchased 5,000 shares at $18.14 per share price, according to the Form-4 filing with the securities and exchange commission.
Phibro Animal Health Corporation is an animal health and mineral nutrition company. The Company is engaged in developing manufacturing and marketing products for a range of food animals including poultry swine beef and dairy cattle and aquaculture. The Company operates through three segments: Animal Health Mineral Nutrition and Performance Products. Its Animal Health segment develops manufactures and markets more than 550 product presentations including antibacterials nutritional specialty products and vaccines. Mineral Nutrition segment manufactures and markets more than 425 formulations and concentrations of trace minerals such as zinc manganese copper iron and other compounds with a focus on customers in North America. The Company’s Performance Products segment manufactures and markets specialty ingredients for use in the personal care automotive industrial chemical and chemical catalyst industries predominantly in the United States.